Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Management of Keloids in the United States, 1990–2009: An Analysis of the National Ambulatory Medical Care Survey

Management of Keloids in the United States, 1990–2009: An Analysis of the National Ambulatory... Background Keloids can cause significant morbidity during wound healing, but the most common current treatment practices for keloids are not well‐established. Objective To determine the main treatments used for keloids in the United States and demographics of patient visits for keloids. Methods The National Ambulatory Medical Care Survey for 1990–2009 was queried for visits with a diagnosis of keloids. Leading medical and procedural treatments, patient demographic characteristics, physician specialties, reasons for visit, and comorbidities were assessed. Results There were an estimated 427,500 visits per year for keloids, with a slight decline in frequency of visits over time (p = .001). Triamcinolone was the leading medical treatment, and excision or destruction of a lesion was the leading procedural treatment. Sixty‐two percent of patients were female, and 23.7% were African American. Mean age was 36.6. Dermatologists managed slightly more than half of visits, and plastic surgeons were second most used. Conclusions Keloids are managed using a variety of treatments, primarily triamcinolone and excision or destruction of a lesion. High‐quality evidence is lacking for the efficacy of most existing keloid treatments. New treatments that improve on the present standard of care would improve outcomes. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Dermatologic Surgery Wolters Kluwer Health

Management of Keloids in the United States, 1990–2009: An Analysis of the National Ambulatory Medical Care Survey

Loading next page...
 
/lp/wolters-kluwer-health/management-of-keloids-in-the-united-states-1990-2009-an-analysis-of-07MHqiwmFT

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
© 2013 American Society of Dermatologic Surgery
ISSN
1076-0512
eISSN
1524-4725
DOI
10.1111/dsu.12182
pmid
23463963
Publisher site
See Article on Publisher Site

Abstract

Background Keloids can cause significant morbidity during wound healing, but the most common current treatment practices for keloids are not well‐established. Objective To determine the main treatments used for keloids in the United States and demographics of patient visits for keloids. Methods The National Ambulatory Medical Care Survey for 1990–2009 was queried for visits with a diagnosis of keloids. Leading medical and procedural treatments, patient demographic characteristics, physician specialties, reasons for visit, and comorbidities were assessed. Results There were an estimated 427,500 visits per year for keloids, with a slight decline in frequency of visits over time (p = .001). Triamcinolone was the leading medical treatment, and excision or destruction of a lesion was the leading procedural treatment. Sixty‐two percent of patients were female, and 23.7% were African American. Mean age was 36.6. Dermatologists managed slightly more than half of visits, and plastic surgeons were second most used. Conclusions Keloids are managed using a variety of treatments, primarily triamcinolone and excision or destruction of a lesion. High‐quality evidence is lacking for the efficacy of most existing keloid treatments. New treatments that improve on the present standard of care would improve outcomes.

Journal

Dermatologic SurgeryWolters Kluwer Health

Published: Jul 1, 2013

References